An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest (2000) 5.12

Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev (2003) 3.79

Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol (2013) 3.55

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood (2010) 2.77

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol (2003) 2.50

Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev (2000) 2.48

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood (2010) 2.10

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood (2014) 1.88

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J (2002) 1.69

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56

Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med (2002) 1.48

CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med (2005) 1.44

Nature and functions of autoantibodies. Nat Clin Pract Rheumatol (2008) 1.43

Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med (2005) 1.40

How I treat autoimmune lymphoproliferative syndrome. Blood (2011) 1.38

Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood (2007) 1.33

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood (2006) 1.31

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. BMC Med Genet (2007) 1.28

New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr (2012) 1.17

Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood (2010) 1.14

Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity (2011) 1.13

Decoy strategies: the structure of TL1A:DcR3 complex. Structure (2011) 1.10

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer (2009) 1.09

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol (2009) 1.08

Critical role for BIM in T cell receptor restimulation-induced death. Biol Direct (2008) 1.02

Countering the 'counterattack' hypothesis. Nat Med (2001) 1.01

Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol (2010) 0.98

Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunol Res (2008) 0.98

Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol (2005) 0.98

Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains. Cell Death Differ (2010) 0.97

The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood. Clin Rheumatol (2003) 0.93

Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J Exp Med (2002) 0.91

Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses. Results Probl Cell Differ (2009) 0.89

Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect (1999) 0.89

Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases. FEBS Lett (2011) 0.87

Apoptosis regulators Fas and Bim synergistically control T-lymphocyte homeostatic proliferation. Eur J Immunol (2010) 0.86

Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunol (2007) 0.84

B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. J Exp Med (2008) 0.84

New approaches to investigating heterogeneity in complex traits. J Med Genet (2003) 0.83

Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation. Haematologica (2010) 0.82

Clustering of distinct autoimmune diseases associated with functional abnormalities of T cell survival in children. Clin Exp Immunol (2000) 0.82

Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cell Immunol (2013) 0.81

Human CD4- 8- T cells are a distinctive immunoregulatory subset. FASEB J (2010) 0.81

Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon. Blood (2009) 0.81

Cervical lymph node diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.81

Novel therapies for memory cells in autoimmune diseases. Clin Exp Immunol (2015) 0.79

Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets (2010) 0.79

Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review. Case Rep Hematol (2011) 0.79

Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases. Clin Exp Immunol (2003) 0.79

Prenatal exposure of mice to diethylstilbestrol disrupts T-cell differentiation by regulating Fas/Fas ligand expression through estrogen receptor element and nuclear factor-κB motifs. J Pharmacol Exp Ther (2012) 0.79

Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production. Sci Rep (2015) 0.77

Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases. Nat Rev Rheumatol (2011) 0.77

Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma. Rheumatol Int (2008) 0.76

The activator of apoptosis Smac-DIABLO acts as a tetramer in solution. Biophys J (2015) 0.75

On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice. Front Immunol (2017) 0.75

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica (2016) 0.75

In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation. Haematologica (2012) 0.75

Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients. Clin Exp Immunol (2002) 0.75

The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell (2001) 12.59

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med (2001) 8.69

Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet (1974) 8.13

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (2000) 6.98

Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol (1996) 6.21

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82

Metabolism of immunoglobulins. Prog Allergy (1969) 5.74

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64

Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (1995) 5.26

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09

Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med (1975) 3.81

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science (2000) 3.72

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med (1998) 3.50

The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43

Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37

T-cell regulation of murine IgA synthesis. J Exp Med (1979) 3.11

Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest (1972) 3.09

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med (1967) 3.06

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00

Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92

Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest (1966) 2.91

Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature (1986) 2.76

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74

Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science (1989) 2.71

NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science (1992) 2.69

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68

X inactivation in females with X-linked disease. N Engl J Med (1998) 2.67

The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol (1976) 2.65

Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol (2000) 2.57

NIH conference. New insights into common variable immunodeficiency. Ann Intern Med (1993) 2.52

Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A (1997) 2.50

Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50

Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50

Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol (1993) 2.48

Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science (1999) 2.45

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol (2001) 2.42

Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol (1992) 2.39

Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med (1996) 2.38

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35

Immunoglobulin gene transcription. Annu Rev Immunol (1991) 2.34

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med (1996) 2.30

Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet (1996) 2.29

Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science (1992) 2.25

Dermatitis herpetiformis: the skin and the gut. Ann Intern Med (1980) 2.24

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro. J Exp Med (1983) 2.19

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med (1996) 2.17

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity (1995) 2.17

TNBS-colitis. Int Rev Immunol (2000) 2.17

The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol (1979) 2.15

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07

Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem (1998) 2.06

Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03

Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J Immunol (1981) 2.03

Incorporation of L-leucine-14C into immunoglobulins by jejunal biopsies of patients with celiac sprue and other gastrointestinal diseases. J Clin Invest (1971) 2.01

Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci STKE (2000) 1.96

Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A (2001) 1.90

A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol (2000) 1.89

Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88

Gluten-sensitive enteropathy: synthesis of antigliadin antibody in vitro. Gut (1974) 1.87

Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med (1996) 1.86

Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) (2001) 1.86

Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol (1998) 1.85

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology (1999) 1.78

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest (1998) 1.77

Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ (1998) 1.76

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74

An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture. J Clin Invest (1974) 1.74

The role of IL-5 in IgA B cell differentiation. J Immunol (1988) 1.73

The pathogenesis of dermatitis herpetiformis. J Invest Dermatol (1978) 1.70

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest (1972) 1.70

Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest (1987) 1.67

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66

NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature (1998) 1.65

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol (2010) 1.65

A receptor for IgA on human T lymphocytes. J Immunol (1979) 1.65

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci U S A (1999) 1.63

Heterogeneity of clinical severity and molecular lesions in Aicardi syndrome. J Pediatr (1990) 1.62

Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis (2000) 1.61

Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60